Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up1.00% Nasdaq Up1.29%




News & Info


Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports


  • Major Holders
  • Insider Transactions
  • Insider Roster


Ranbaxy Laboratories Ltd. (RANBAXY.BO)

468.05 Up 1.90(0.41%) 3:43AM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Ranbaxy Laboratories Ltd.
Devika Tower
12th Floor
New Delhi, 110019
India - Map
Phone: 91 11 2623 7508
Fax: 91 11 2622 5987

Index Membership:N/A
Industry:Drugs - Generic
Full Time Employees:N/A

Business Summary 

Ranbaxy Laboratories Limited, a pharmaceutical company, engages in the manufacture, marketing, and sale of pharmaceuticals products. It offers generic pharmaceuticals, branded generics, active pharmaceutical ingredients and intermediates, anti-retrovirals, and over-the-counter products. The company’s products are used for the treatment of chronic and lifestyle diseases in the areas of cardiovascular, central nervous system, respiratory, dermatology, orthopedics, nutritional, and urology, as well as in the areas of gastroenterology, anti-infectives, pain and musculoskeletal, and endocrine and metabolic. It operates primarily in India, Europe, North America, the Asia Pacific, and Africa. The company was founded in 1961 and is headquartered in New Delhi, India. Ranbaxy Laboratories Limited is a subsidiary of Daiichi Sankyo Company, Ltd.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Ranbaxy Laboratories Ltd.

Key Executives 
Mr. Arun Sawhney B.Com., P.G.D.B.M., 59
Managing Director, Chief Exec. Officer, Exec. Director, Member of Shareholders/Investors Grievance & Share Transfer Committee and Member of Science Committee
Mr. Takashi Shoda , 66
Non-Exec. & Non-Independent Director, Member of Science Committee, Chief Exec. Officer of Daiichi Sankyo and Pres of Daiichi Sankyo
Mr. Indrajit Banerjee , 58
Pres and Chief Financial Officer
Mr. Ranjit Kohli ,
Director of Global Accounts
Mr. David Briskman ,
Chief Information Officer and VP
Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in INR.